Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Long-term medication in schizophrenic psychoses].

W Gaebel1

  • 1Psychiatrische Klinik, Heinrich-Heine-Universität Düsseldorf. wolfgang.gaebel@uni-duesseldorf.de

Fortschritte Der Neurologie-Psychiatrie
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risks of digitalization in mental health care.

Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater·2025
Same author

EPA guidance on treatment of negative symptoms in schizophrenia.

European psychiatry : the journal of the Association of European Psychiatrists·2021
Same author

EPA guidance on assessment of negative symptoms in schizophrenia.

European psychiatry : the journal of the Association of European Psychiatrists·2021
Same author

EPA guidance on the quality of mental health services: A systematic meta-review and update of recommendations focusing on care coordination.

European psychiatry : the journal of the Association of European Psychiatrists·2020
Same author

[Quality psychiatry and destigmatization : Can quality psychiatry and psychotherapy contribute to destigmatization of mental illnesses?]

Der Nervenarzt·2020
Same author

Factors associated with the onset of major depressive disorder in adults with type 2 diabetes living in 12 different countries: results from the INTERPRET-DD prospective study.

Epidemiology and psychiatric sciences·2020

Maintenance treatment for schizophrenia, primarily focused on relapse prevention, is empirically supported. Personalized long-term care is possible with newer antipsychotic medications and evidence-based treatment guidelines.

Area of Science:

  • Psychiatry
  • Neuroscience

Context:

  • Schizophrenia is a chronic, relapsing psychiatric disorder.
  • Effective relapse prevention is crucial for managing schizophrenia.
  • Long-term treatment strategies are essential for patient well-being.

Purpose:

  • To summarize the importance of maintenance treatment in schizophrenia.
  • To highlight the role of antipsychotic medications in relapse prevention.
  • To emphasize the utility of treatment guidelines in clinical practice.

Summary:

  • Neuroleptic maintenance therapy effectively prevents relapses in schizophrenia, a fact supported by empirical evidence.
  • Individualized long-term treatment plans can be developed utilizing newer antipsychotic drugs with favorable risk-benefit profiles.

Related Experiment Videos

  • Scientific medical societies provide treatment guidelines to aid practitioners in optimal patient management.

    • Impact:

    • Improved patient outcomes through sustained remission and reduced relapse rates.
    • Enhanced clinical decision-making for healthcare providers managing schizophrenia.
    • Facilitation of personalized and effective long-term care for individuals with schizophrenia.